Company: INV
Filing Date: 2025-04-23
Form Type: 424B3
Source: 0001628280-25-019358
Chunk: 208

Company: Innventure, Inc.
Filing Date: 2025-04-23
Form: 424B3
Chunk 208
---
Date Fair Value(per share) |
| Granted on December 9, 2024........................................................                 |         975,409 |     |                        $12.20 |     |                                           $6.63 |
| Vested............................................................................................. |          61,560 |     |                         12.20 |     |                                            6.63 |
| Exercised........................................................................................   |               — |     |                             — |     |                                               — |
| Forfeited.........................................................................................  |               — |     |                             — |     |                                               — |
| Outstanding at December 31, 2024................................................                    |         913,849 |     |                        $12.20 |     |                                           $6.63 |
| Exercisable at December 31, 2024.................................................                   |               — |     |                             — |     |                                               — |

During the Successor period from October 2, 2024 through December 31, 2024 , the Company recognized compensation costs related to the stock options of $405 within General and administrative expense in the consolidated statements of operations and comprehensive income (loss) . As of December 31, 2024 , the Company had $6,063 in compensation expense remaining to be recognized over approximately 1.68 years . Stock Appreciation Rights On December 31, 2024 the Company granted 350,000 stock appreciation rights with respect to the equity of Accelsius Holdings LLC. The SARs were awarded to certain Innventure directors, officers, and former service providers of the Company and its affiliates (the “Participants”). The SARs entitle the Participants to shares of Common Stock, or cash, equal to the value of the appreciation in Accelsius’ stock price over the base price of $12.175 . Two Participants, who were considered non-employees, were granted cash-settled SARs and three Participants were granted stock-settled SARs. The cash-settled SARs are considered liability-classified and the stock-settled SARs are considered equity-classified Both the cash-settled SARs and stock-settled SARs will be automatically exercised upon the two -year anniversary of the date of grant. The weighted average contractual term is 2 years .

F-42 Innventure, Inc. and Subsidiaries Notes to Consolidated Financial Statements (in thousands, except share or per share data)

The estimated grant date fair value of the cash-settled SARs and the stock-settled